Beta Bionics (BBNX) Other Operating Expenses (2024 - 2026)

Beta Bionics has disclosed Other Operating Expenses across 3 years of filings, most recently posting $20.7 million for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $20.7 million, up 54.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $68.7 million (up 60.51% YoY), and the FY2025 annual result was $61.4 million, up 65.57% from the prior year.
• Other Operating Expenses came in at $20.7 million for Q1 2026 at Beta Bionics, up from $16.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $20.7 million in Q1 2026 to a low of $7.7 million in Q1 2024.
• The 3-year median for Other Operating Expenses is $13.4 million (2025), against an average of $13.2 million.
• Peak annual rise in Other Operating Expenses reached 74.89% in 2025, while the deepest fall reached 51.18% in 2025.
• Beta Bionics' Other Operating Expenses stood at $10.8 million in 2024, then jumped by 51.18% to $16.3 million in 2025, then gained by 26.94% to $20.7 million in 2026.
• The last three Other Operating Expenses figures came in at $20.7 million (Q1 2026), $16.3 million (Q4 2025), and $16.0 million (Q3 2025), per Business Quant data.